Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Dec. 7, 2017, 7:38 a.m. EST

Pacira Pharmaceuticals names Scott Braunstein COO, Richard Scranton as chief scientific officer

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pacira BioSciences Inc. (PCRX)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

Pacira Pharmaceuticals Inc. /zigman2/quotes/202929053/composite PCRX -0.40% said Thursday it has named Scott Braunstein as chief operation officer and Richard Scranton as chief scientific officer. Scranton will head research, while leading communications and market access for Exparel, the company's non-opioid treatment for managing post-surgical pain. Shares were not yet active premarket, but have gained 34% in 2017, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.27% has gained 17%.

/zigman2/quotes/202929053/composite
US : U.S.: Nasdaq
$ 52.31
-0.21 -0.40%
Volume: 86,892
Oct. 20, 2021 1:28p
P/E Ratio
13.38
Dividend Yield
N/A
Market Cap
$2.33 billion
Rev. per Employee
$688,537
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,531.72
+12.09 +0.27%
Volume: 1.02B
Oct. 20, 2021 1:30p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.